dianhydrogalactitol has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gál, F; Institóris, E; Otvös, L; Szikla, K | 1 |
| Fan, YJ; Han, R; Li, M; Zhou, J | 1 |
2 other study(ies) available for dianhydrogalactitol and Leukemia L 1210
| Article | Year |
|---|---|
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carmustine; Cross-Linking Reagents; Dianhydrogalactitol; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Sugar Alcohols | 1989 |
[Experimental studies of the combination of vincristine and 1,2:5,6-dianhydrogalactitol].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dianhydrogalactitol; Drug Synergism; Leukemia L1210; Mice; Mice, Inbred DBA; Vincristine | 1987 |